Soleus Capital Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Soleus Capital Management's RVMD Position: Q3 2026 in Review
Soleus Capital Management opened a new position in Revolution Medicines (RVMD) in Q3 2026: 36,249 shares worth $7.44M. The stake represents 0.26% of the portfolio and ranks #63 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in RVMD as recently as Q2 2025.
Soleus Capital Management first reported a position in RVMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $33.2M in Q2 2024. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Soleus Capital Management held 36,249 shares of Revolution Medicines worth $7.44M as of Q3 2026.
- Revolution Medicines was a new Soleus Capital Management position in Q3 2026.
- Revolution Medicines made up 0.26% of Soleus Capital Management's portfolio in Q3 2026, its #63 holding.
- Soleus Capital Management first reported a position in Revolution Medicines in Q1 2021 and has held it in 10 quarters since.
- Soleus Capital Management's Revolution Medicines position peaked at $33.2M in Q2 2024.
- 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.